A systematic review of Radiesse/calcium hydroxylapatite and carboxymethylcellulose: evidence and recommendations for treatment of the face

Abstract

Radiesse® is a filler composed of calcium hydroxylapatite microspheres suspended in a carboxymethylcellulose gel (CaHA/CMC). It has robust rheological properties that have been associated with its versatility. CaHA/CMC is employed for both on‐label indications of filling wrinkles or lines, volumizing, and contouring of areas as well as off‐label indications aiming at biostimulation and skin tightening. However, despite the expanding use of CaHA/CMC, overall evidence and recommendations for treatment are currently lacking. This paper aims to provide an up‐to‐date overview of CaHA/CMC clinical applications, together with a level of evidence of supporting literature, focusing on the face. Based on the data, CaHA/CMC may be considered a safe and effective treatment option for cheeks, jawline, HIV‐related facial lipoatrophy, and nasolabial folds. Treatment of marionette lines, chin, pre‐jowl, and corner of the mouth also tends to respond with a high degree of efficacy. Despite the recent trend, guidelines, and safety profile of diluted and hyperdiluted Radiesse®, no randomized controlled trials have been published.

A systematic review of Radiesse® (calcium hydroxylapatite): evidence and recommendations for the body

“…One such injectable is the biostimulant Radiesse® (Merz Aesthetics), a filler composed of 30% calcium hydroxylapatite (CaHA) and 70% carboxymethylcellulose (CMC) gel carrier, CaHA/CMC 4 . Since its approval in 2006, the literature over the past 20 years has seen it deployed on the face and dorsal aspects of the hands, both of which are FDA‐approved indications 4–7 . However, several experiences worldwide have provided data on its application in different body areas, from the neck to the feet 8,9 …”